Search

everythinglearnresearchcommunity

for

Search:↓

Injecting monocyto-angiotropin into hare skin increases hair growth by forming new blood vessels.

A young woman with severe symptoms of CPAN improved with intensive treatment but needed a leg amputation.

Aminoguanidine increases a specific growth signal in stored hair grafts, which may help them survive better after being transplanted.

Promising cancer treatments were found, but the manufacturer closed.

New hair loss treatment using marine collagen and dissolvable needles improves hair growth.

Personalized treatments for hair loss are becoming more effective by using genetic information.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

Abnormal contraction of connective tissue in hair follicles causes hair loss by killing off important cells, and treating this could improve hair growth.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.

Hair loss may indicate higher risk of heart disease.

Certain proteins are found at higher levels in balding areas compared to non-balding areas, suggesting a link to hair loss. This could be useful for diagnosing and treating hair loss.

Specific RNA patterns are linked to alopecia areata.

CEC levels may be a useful marker for predicting prostate cancer progression.

The YH complex, made from certain plant extracts, effectively promotes hair regrowth and could be a potential treatment for hair loss.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

The study looked at how common male pattern baldness is in young men in a heart care unit but didn't give specific results.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.

Non-coding RNAs may be key in diagnosing and treating rare skin disorders.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

Increased PPARGC1α relates to hair thinning in common baldness.

Combining plant extracts with nanotechnology may improve hair loss treatments.

Machine learning optimized microneedles promote hair regrowth better than minoxidil without safety risks.

ABCD1 gene mutations cause adrenomyeloneuropathy, leading to symptoms like limb weakness and spasticity, with management focusing on rehabilitation and spasticity treatment.

NF-κB levels can help diagnose and assess the severity of androgenetic alopecia.

Using growth factor injections and minoxidil together can significantly improve hair growth in people with hair loss.

A botanical extract was found to be a safe treatment that may prevent hair loss in chemotherapy patients.

Activating the GDNF-GFRα1-RET signaling pathway could potentially promote skin and limb regeneration in humans and could be used to treat hair loss and promote wound healing.